US Patent Issued to ModernaTX on March 4 for "Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,742, issued on March 4, was assigned to ModernaTX Inc. (Cambridge, Mass.).

"Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2" was invented by Paolo Martini (Boston), Stephen Hoge (Cambridge, Mass.), Kerry Benenato (Cambridge, Mass.), Vladimir Presnyak (Manchester, N.H.), Iain McFadyen (Medford, Mass.), Ellalahewage Sathyajith Kumarasinghe (Cambridge, Mass.), Jingsong Cao (Cambridge, Mass.), Lin Tung Guey (Lexington, Mass.) and Staci Sabnis (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to mRNA therapy for the treatment of Citrullinemia Type 2 ("CTLN2"). mRNAs for use in the invention, ...